Arno G. Motulsky, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
The clinical implications of mutations can best be demonstrated by the hemoglobinopathies and enzymopathies. Mutations affecting hemoglobins and enzymes can have three types of effect: molecular alterations causing disease, such as certain hemolytic anemias, polycythemias, and methemoglobinemia; molecular alterations, causing disease only in certain environments, such as drug sensitivities caused by hemoglobin and glucose-6-phosphate dehydrogenase (G6PD) variants; molecular alterations without clinical consequences. Over 100 hemoglobin mutations and over 80 G6PD variants are known. Many are rare; others are frequent in certain populations and owe their origin to a selective survival advantage in the past. The clinical and genetic biology of
Motulsky AG. Genetic Aspects of Hemoglobins and Red Cell Enzymes.. Ann Intern Med. 1971;74:844. doi: 10.7326/0003-4819-74-5-844_2
Download citation file:
Published: Ann Intern Med. 1971;74(5):844.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use